Top London Pharmaceutical Companies (45)
Don't see your company?
Create a company profile
A science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our three global businesses, scientific and technical know-how and talented people.
MultiplAI Health is a preventive medicine company pioneering blood screening for cardiovascular and other complex diseases. Powered by genomic RNAseq, proprietary data transformation, and comprehensive AI analysis, our test transforms a single blood sample into a precision, actionable risk assessment to drive proactive health management that will extend lifespan. We have a laboratory-validated prototype and are conducting our sixth clinical study to achieve technical validation of our whole-blood liquid biopsy approach in the cardiovascular space
Medicspot operates from within pharmacy consulting rooms, allowing instant and on-demand GP consultations. Using state-of-the-art diagnostic devices and secure video calling, we connect patients with a UK based clinician. Any prescription medication can be collected right away, saving the patient a second trip
Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona. Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, only supportive therapies are currently available. For patients with end-stage liver disease (cirrhosis) the only therapeutic option is liver transplantation, a complex surgical procedure limited by complications and a shortage of donors. At Resolution Therapeutics, we are developing a macrophage cell therapy product to treat patients at risk of liver decompensation, thus helping them avoid the need for a liver transplant.
We are developing machine learning models for drug discovery and software for facilitating and automating research in the life-sciences industry.
Breezie is a tablet interface proven to engage seniors irrespective of their technical capabilities. Breezie helps seniors lead a happier, healthier and independent life as long as possible by keeping them socially connected and providing mental engagement with access to a wide range of content. It runs on an open platform that enables senior living providers to deliver their own and third party services and content in a simple format for seniors which can deliver better care at lower costs. The Caregiver’s Hub allows a family member or caregiver to remotely personalize and handpick the services most relevant to the senior
Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI and machine learning analytics
We are the first in class pre-clinical translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered targets.
We are better working together. Wondr Medical seamlessly connects the health community on a global scale, transforming the ways we learn, share, discuss and treat. Compliancy, guaranteed
Symmetron is an established boutique health economics and health outcomes research consultancy that helps companies realise and communicate the value of their drugs and devices. Our mission is to increase access to healthcare that saves lives and improves quality of life for people around the world. We provide a full range of services for clients seeking market access and reimbursement in Europe, North America, Asia and Australia, including: • Evidence development • Health economic modelling • Health technology assessment • Statistical analysis of trial data • Scientific writing • Training and workshops We have experienced significant success since 2008, achieving market access for dozens of healthcare products and launching several blockbuster pharmaceuticals. We have published over 100 scientific articles, expanded our core service offerings and enjoyed steady growth fueled by the reputation of our exceptional team. Clients tell us they repeatedly return to us and refer us because of our: • Team stability – ‘With Symmetron you know what team you're going to get, so you can always give a solid recommendation to others’ • Integrity, honesty and transparency – ‘It’s great to be able to talk to someone honest and practiced’ • Flexibility, agility and pragmatism – ‘Team thinks out of the box and can move quickly’ • Professionalism and technical expertise – ‘Always delivered rigorous research and rock-solid timely results’ • Partnership – ‘Symmetron felt more like an extension of our own team’
We are uniting science, technology and talent to get ahead of disease together.
Cancer Research UK is the world's leading cancer charity dedicated to saving lives through research, influence and information. Nearly one in two of us will get cancer in our lifetime, but we’re finding new ways to outsmart it, so that more people can live longer, better lives free from the fear of cancer. We carry out scientific research to help prevent, diagnose and treat cancer and our groundbreaking work, funded almost entirely by the general public, will ensure that millions more people survive. Together we are beating cancer. Registered charity No. 1089464
Pulmocide is a biopharmaceutical company that specializes in tackling difficult-to-treat respiratory diseases. We focus on respiratory fungal infections that can be serious and life-threatening and have significant effects on patients’ quality of life. Our current clinical development focus is on treating patients who have not successfully responded to the standard of care and on the prophylactic treatment of lung transplant patients. Pulmocide’s innovative approach to drug development provides a novel potential therapy that has been specifically designed to treat the most common fungal lung disease, pulmonary aspergillosis. Opelconazole was designed for inhaled delivery to minimize systemic exposure and deliver a high concentration of drug with a long retention time at the site of infection. This approach could improve treatment outcomes in patients with fungal lung disease without increasing systemic side effects and without interactions with other medications. The Pulmocide team is well experienced in the discovery and development of inhaled therapies for respiratory and infectious disease indications. They have particular expertise in the identification of novel compounds that can be delivered directly to the lungs.
Causaly amplifies human cognitive abilities to expand the boundaries of discovery towards making the best decisions in Biomedicine. To achieve this, we are teaching computers to read all knowledge ever published and develop an interface that allows humans to answer questions they can’t ask anywhere else.
ENBIOSIS Biosciences reaches deep into your inner world with microbiome analysis and offers you the key for a sustainable and healthy life
Atlas Biomed is a personalized health company applying the latest genetic technologies to inspire consumers into a positive lifestyle change, and lead them into a healthier future.
We believe that everyone - irrespective of who they are or where they live - deserve medications that work
HTN Best Solution for Connecting Healthcare Award 2023 | Digitally empowering independent community pharmacies to deliver more private services, reducing their reliance on NHS revenues, and making them more accessible so that your local community will have better access to healthcare services in the UK.
At Opvia, we empower R&D, manufacturing and quality management teams to build custom process operating systems that streamline their workflows and give them a competitive edge. We work with fast-growing startups and enterprises across a range of industries, including biotech, pharma, food and beverages, engineering and medical devices, to help them digitize their processes and bring innovative products to market faster. With our powerful tools and expert support, we give companies the freedom to create and deliver like never before.
Virtual Science AI is reimagining how the Healthcare Industry generates external stakeholder insights. These insights are delivered via our unique and ground breaking artificial Intelligence platform, and are faster, clearer and more actionable. AI-driven analytics created through interactive data analysis, including sentiment analysis reports, ensure immediate actionable insights. The engagement of HCP's, patient experts, payers and other stakeholders provides end-to-end advisory services powered by our 24/7 engagement platform. Through asynchronized working, our clients determine key strategic insights that refine scientific and commercial messaging. The generation of these insights shapes the building of robust strategies that are co-created with HCP's, patients, payers and communities ensuring successful market dynamics and improving long-term patient care. The capitalisation of the company via Venture Capital and Health Tech funds is a reflection of the dynamic, exciting and innovative nature of our mission. Contact us now via our website, as we would love to demonstrate the significant benefits that our AI software platform will bring to your insight generation. http://www.virtualscienceai.com Take your insight generation to the next dimension
Work Your Passion. Live Your Purpose.
